Description
Disease Indications
Risk of cardiovascular events
Manufacturer
Novartis
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Price range: $40.00 through $350.00
Entresto (sacubitril/valsartan) is a heart medication used to treat adults with long-term heart failure who have symptoms of the disease.
Disease Indications
Risk of cardiovascular events
Manufacturer
Novartis
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
| Package Tablets | 60 capsules x 6 mg/6 mg, 56 tablets of 24 mg/26 mg, 196 tablets of 24 mg/26 mg, 56 tablets of 97 mg/103 mg |
|---|
Reviews
There are no reviews yet.